UPDATE : Wednesday, January 23, 2019
상단여백
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy
Kanzen said Tuesday that it has signed an agreement with Corea Therapeutics...
by Lee Han-soo  |  2019-01-23 21:29
라인
Philips Korea to increase market share for CPAP with connected care strategy
Phillips Korea aims to expand its market share in the continuous positive a...
by Lee Han-soo  |  2019-01-23 16:21
라인
Lilly returns rights for Hanmi’s BTK inhibitor candidate
Hanmi Pharmaceutical said Wednesday that Lilly has returned licensing right...
by Lee Han-soo  |  2019-01-23 10:21
라인
Bridge Biotherapeutics licenses in new immunotherapy candidate
Bridge Biotherapeutics said Wednesday that it has signed a technology trans...
by Lee Han-soo  |  2019-01-23 10:20
라인
Court suspends FSC’s disciplinary ruling against Samsung BioLogics
The Seoul Administrative Court has suspended the Financial Services Commiss...
by Lee Han-soo  |  2019-01-22 22:30
라인
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment
CJ Healthcare said Tuesday that it has signed an agreement with Chong Kun D...
by Lee Han-soo  |  2019-01-22 16:03
라인
‘We Want Healthcare’ introduces Lunit AI to its screening system
Lunit, a medical artificial intelligence (AI) company, said Tuesday that it...
by Lee Han-soo  |  2019-01-22 14:56
라인
‘Appendicitis patients' prognosis remains similar if surgery is done within 24 hours’
If only people with appendicitis get surgery within 24 hours of its breakou...
by Lee Han-soo  |  2019-01-22 14:55
라인
BMS, Ono Pharma wins more indication for Opdivo in EU
Bristol-Myers Squibb (BMS) and Ono Pharma Korea have received an additional...
by Lee Han-soo  |  2019-01-21 18:01
라인
JW wins sales go-ahead for hemophilia A treatment
JW Pharmaceutical said Sunday that the Ministry of Food and Drug Safety has...
by Lee Han-soo  |  2019-01-21 15:35
라인
Novo Nordisk increases market share for mixed insulin in Korea
Novo Nordisk Korea said Monday that Ryzodeg, the company’s soluble insulin ...
by Lee Han-soo  |  2019-01-21 14:44
라인
Sillajen releases interim results for combination cancer treatment in US
Sillajen said Monday that it has presented the National Cancer Institute’s ...
by Lee Han-soo  |  2019-01-21 14:20
라인
FDA OKs Samsung Bioepis’ first oncology medicine
Samsung Bioepis said Monday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2019-01-21 11:43
라인
Top Court’s ruling affects local companies’ base-altering strategies to avoid patents
Local pharmaceutical companies may no longer be able to avoid patent claims...
by Lee Han-soo  |  2019-01-18 16:36
라인
OliX unveils new drug candidate for treating geographic atrophy
Olix Pharmaceutical unveiled its latest drug candidate OLX10020, a treatmen...
by Lee Han-soo  |  2019-01-18 15:17
라인
Celltrion wins patent dispute on Truxima
Celltrion said Friday that it has won the domestic patent appeal for chroni...
by Lee Han-soo  |  2019-01-18 11:47
라인
Over 1,000 bio-ventures set up in past 3 years
Korea’s bio-venture business boom peaked in 2016 and turned downward, but a...
by Lee Han-soo  |  2019-01-17 22:05
라인
Daewoong to use cloud service for safe drug management
Daewoong Pharmaceutical said Thursday that it has introduced Oracle Argus C...
by Lee Han-soo  |  2019-01-17 15:37
라인
AMC develops tech to make infinite medical AI learning data
Researchers at Asan Medical Center (AMC) have developed a technology for pr...
by Lee Han-soo  |  2019-01-17 14:36
라인
EN Cell to make Hanmi’s anti-cancer gene stem cell therapy
EN Cell said Thursday that it has signed a contract manufacturing organizat...
by Lee Han-soo  |  2019-01-17 12:34
여백
여백
여백
Back to Top